Japanese Journal of Clinical Oncology 32:3-8 (2002)
© 2002 Foundation for Promotion of Cancer Research
Methylation Status and Expression of Human Telomerase Reverse Transcriptase mRNA in Relation to Hypermethylation of the p16 gene in Colorectal Cancers as Analyzed by Bisulfite PCR-SSCP
1Division of Clinical Laboratory, 2Division of Surgery and 3Director, National Cancer Center Hospital, Tokyo, Japan
Background: The expression level of human telomerase reverse transcriptase (hTERT) is correlated with telomerase activity and is expressed at high levels in malignant tumors. It is of interest whether expression of hTERT is regulated by methylation of the CpG island in the promoter of the hTERT gene. We examined hTERT expression and methylation status of the hTERT and other genes including p16.
Methods: We analyzed methylation status by bisulfite treatment and polymerase chain reaction with single-strand conformation polymorphism analysis (PCR-SSCP) and expression of the hTERT by RT-PCR, in 13 cancer cell lines, eight white blood cell samples and 24 colorectal cancer tissues.
Results: In the cancer cell lines, hTERT was expressed and the CpG island of the hTERT promoter was methylated. Most colorectal cancer tissues showed similar results. The promoter of hTERT was methylated in six cases, partially methylated in 17 cases and unmethylated in one case. All cases with methylation of hMLH1 or p16 also showed methylation of hTERT; however, some of the cases lacking p16 methylation also had hTERT methylation.
Conclusion: Increased expression of hTERT is related to hypermethylation of hTERT in colorectal cancerous tissues as well as some cancer cell lines and disconcordant with hypermethylation of p16.
+ For reprints and all correspondence: Masato Maekawa, Department of Laboratory Medicine, Hamamatsu University School of Medicine, Handayama 1–20–1, Hamamatsu, 431-3192, Japan. E-mail: mmaekawa@hama-med.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Kageyama, K. Shinmura, H. Yamamoto, M. Goto, K. Suzuki, F. Tanioka, T. Tsuneyoshi, and H. Sugimura Fluorescence-labeled Methylation-sensitive Amplified Fragment Length Polymorphism (FL-MS-AFLP) Analysis for Quantitative Determination of DNA Methylation and Demethylation Status Jpn. J. Clin. Oncol., April 1, 2008; 38(4): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A P Moulin, G Clement, F T Bosman, L Zografos, and J Benhattar Methylation of CpG island promoters in uveal melanoma Br. J. Ophthalmol., February 1, 2008; 92(2): 281 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Oikonomou, I. Messinis, and A. Tsezou DNA Methylation Is Not Likely to Be Responsible for hTERT Expression in Premalignant Cervical Lesions Experimental Biology and Medicine, July 1, 2007; 232(7): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Renaud, D. Loukinov, Z. Abdullaev, I. Guilleret, F. T. Bosman, V. Lobanenkov, and J. Benhattar Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene Nucleic Acids Res., February 28, 2007; 35(4): 1245 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Zinn, K. Pruitt, S. Eguchi, S. B. Baylin, and J. G. Herman hTERT Is Expressed in Cancer Cell Lines Despite Promoter DNA Methylation by Preservation of Unmethylated DNA and Active Chromatin around the Transcription Start Site Cancer Res., January 1, 2007; 67(1): 194 - 201. [Abstract] [Full Text] [PDF]
|
|